EIF2AK2 and colitis: Additionally, luteolin could also be effective against inflammatory conditions such as colitis in which the involvement of PACT-PKR pathway is established (Farabaugh et al., 2017; Farabaugh et al., 2020; Chukwurah et al., 2021).